Robert S Stern. Show Affiliations »
Abstract
Mesh： See more » Administration, CutaneousCalcineurin InhibitorsDermatitis, Atopic/drug therapyDrug ApprovalDrug LabelingHumansImmunosuppressive Agents/administration & dosageImmunosuppressive Agents/adverse effectsTacrolimus/administration & dosageTacrolimus/adverse effectsTacrolimus/analogs & derivativesUnited StatesUnited States Food and Drug Administration
Substances： See more » Calcineurin InhibitorsImmunosuppressive AgentspimecrolimusTacrolimus
Year: 2006 PMID： 16983018 DOI： 10.1001/archderm.142.9.1233
Source DB: PubMed Journal: Arch Dermatol ISSN： 0003-987X